Weight management medication, such as semaglutide and liraglutide, can only be accessed with specialist weight management services. But it is recognised that the provision of specialist weight management services varies nationally, and many people who are eligible for weight management medication do not have access to these services. Digital weight management technologies deliver specialist services of a multidisciplinary team through various app features and digital platforms. By providing the specialist weight management services through remote delivery, digital weight management technologies can potentially improve access to weight management treatment. These technologies could also reduce the number of in person appointments and increase the capacity of service delivery in areas that have established services. The multidisciplinary team accessed via the digital weight management technologies are likely to include a dietician, wellness coach, psychologist and diabetic nurse specialist. This early value assessment is being developed to evaluate technologies that provide multidisciplinary support but do not facilitate weight management medication monitoring or prescribing as part of the technology. These technologies could be used alongside GP services, pharmacists, or specialist prescribers in primary care to provide a full specialist weight management service. Technologies included in GID-HTE10007 Digitally enabled weight management programmes to support treatment with weight management medication: early value assessment, facilitate weight management medication monitoring or prescribing.
Status In progress
Technology type Device
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources

Provisional Schedule

Expected publication 06 March 2024

Project Team

Project lead Liz Islam

Email enquiries


Key events during the development of the guidance:

Date Update
18 January 2024 Committee meeting
02 November 2023 - 17 November 2023 Draft guidance
23 August 2023 Scope published
04 July 2023 In progress. Topic launched